Atlas Trials

A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Clinical trial NCT07421232 · COMPLETED

Trial details

NCT number
NCT07421232
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypercholesterolemia and Mixed Hyperlipidemia
Start date
2024-12-03
Primary completion
2025-08-30
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.